Indee

Indee Labs is a biotechnology startup developing the µVS Delivery SystemTM for cell therapy and high throughput screening in collaboration with multiple pharmaceutical and biotechnology companies, select academics along with the National Cancer Institute and the National Institute for Allergy and Infectious Diseases. The team at Indee Labs has demonstrated revolutionary improvements over existing methods including scalability, high yield, negligible perturbation of the immune cell state along with rapid processing of research-, clinical- and commercial-scale samples with a simple workflow and a small footprint. Indee Labs is backed by IndieBio/SOSV, Y Combinator, Social Capital, Main Sequence Ventures, Founders Fund's FF Science among others.